Fatemeh Elahian
Overview
Explore the profile of Fatemeh Elahian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heidari R, Assadollahi V, Marashi S, Elahian F, Mirzaei S
Biomed Res Int
. 2025 Feb;
2025:5538575.
PMID: 39949372
Long noncoding RNA (lncRNA) plays a critical role in cancer cell proliferation, invasion, metastasis, and chemoresistance. The current study introduces novel lncRNAs in colorectal cancer (CRC) through bioinformatics analysis. GSE134834...
2.
Heidari R, Assadollahi V, Marashi S, Elahian F, Mirzaei S
Cancer Rep (Hoboken)
. 2025 Jan;
8(1):e70098.
PMID: 39764737
Background: Bioinformatics analysis of hepatocellular carcinoma (HCC) expression profiles can aid in understanding its molecular mechanisms and identifying new targets for diagnosis and treatment. Aim: In this study, we analyzed...
3.
Heidari R, Assadollahi V, Shakib Manesh M, Mirzaei S, Elahian F
Int J Pharm
. 2024 Sep;
665:124654.
PMID: 39244073
Wound healing is a natural process that can be disrupted by disease. Nanotechnology is a promising platform for the development of new therapeutic agents to accelerate acute and chronic wound...
4.
Hosseini S, Elahian F, Mirzaei S
Int J Biol Macromol
. 2024 Sep;
279(Pt 2):135239.
PMID: 39218175
There are lots of gene editing tools for targeting genome sequences. Some are almost known, and most are a complete mystery and undiscovered. CRISPR/Cas editing tools have brought about a...
5.
Karimzadeh F, Soltani Fard E, Nadi A, Malekzadeh R, Elahian F, Mirzaei S
J Mater Chem B
. 2024 Jun;
12(25):6033-6062.
PMID: 38887828
The skin, serving as the body's outermost layer, boasts a vast area and intricate structure, functioning as the primary barrier against external threats. Disruptions in the composition and functionality of...
6.
Mahdi-Esferizi R, Shiasi Z, Heidari R, Najafi A, Mahmoudi I, Elahian F, et al.
BMC Cancer
. 2024 Mar;
24(1):371.
PMID: 38528462
Background: The need for intelligent and effective treatment of diseases and the increase in drug design costs have raised drug repurposing as one of the effective strategies in biomedicine. There...
7.
Abdali N, Nadipour Borujeni M, Hosseini S, Malekzadeh R, Abolhasani M, Mirzaei S, et al.
Cell Biol Int
. 2024 Mar;
48(6):861-871.
PMID: 38480672
The possible interactions of morphine, paynantheine and speciociliatine alkaloids with ATP-binding cassette (ABC) transporters was investigated. The compounds were docked against ABCG2 and ABCB1 to predict the binding mode of...
8.
Hosseini S, Ghatrehsamani M, Yaghoobi H, Elahian F, Mirzaei S
Epigenomics
. 2024 Feb;
16(5):277-292.
PMID: 38356395
The objective of this research was to determine whether HDAC2 function is associated with gastric cancer progression. HDAC2 was knocked out in EPG85.257 cells using CRISPR/Cas9 and tumorigenesis pathways were...
9.
Heidari R, Assadollahi V, Khosravian P, Mirzaei S, Elahian F
Int J Biol Macromol
. 2023 Sep;
253(Pt 4):127060.
PMID: 37774811
The use of nucleic acid to control the expression of genes relevant to tumor progression is a key therapeutic approach in cancer research. Therapeutics based on nucleic acid provide novel...
10.
Mahdi-Esferizi R, Hoseyni B, Mehrpanah A, Golzade Y, Najafi A, Elahian F, et al.
BMC Bioinformatics
. 2023 Jul;
24(1):275.
PMID: 37403016
Background: P4 medicine (predict, prevent, personalize, and participate) is a new approach to diagnosing and predicting diseases on a patient-by-patient basis. For the prevention and treatment of diseases, prediction plays...